Short Interest in CSL Limited (OTCMKTS:CSLLY) Grows By 151.1%

CSL Limited (OTCMKTS:CSLLY) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 11,800 shares, a growth of 151.1% from the December 15th total of 4,700 shares. Based on an average trading volume of 159,800 shares, the short-interest ratio is presently 0.1 days.

CSL Stock Up 0.4 %

Shares of OTCMKTS:CSLLY traded up $0.39 during midday trading on Wednesday, hitting $87.26. The company’s stock had a trading volume of 269,487 shares, compared to its average volume of 90,010. The company has a current ratio of 2.18, a quick ratio of 0.97 and a debt-to-equity ratio of 0.58. The stock’s 50 day simple moving average is $89.40 and its 200 day simple moving average is $96.63. CSL has a fifty-two week low of $83.31 and a fifty-two week high of $109.00.

CSL Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.